-+ 0.00%
-+ 0.00%
-+ 0.00%

Citius Pharma Q4 EPS $(0.11) Beats $(0.43) Estimate

Benzinga·12/23/2025 21:36:35
語音播報
Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.43) by 74.42 percent. This is a 93.6 percent increase over losses of $(1.72) per share from the same period last year.